B, evaluation of the amount of IFN- secreting tumor-reactive cells in the spleens of mice following DC-lysate vaccinations
B, evaluation of the amount of IFN- secreting tumor-reactive cells in the spleens of mice following DC-lysate vaccinations. of choice for preparing whole tumor lysate vaccine. We then designed and conducted a pilot clinical study to test the biological effects of HOCl-oxidized autologous whole tumor lysate-pulsed DCs (i.e. OCDC vaccine) in five subjects with recurrent…